Wednesday morning our CIO of Arctic Aurora LifeScience, Ulrica Slåne Bjerke, attended Börslunch at EFN. She discussed the Health Care sector in the present economic conditions, as well as the future prospects of the sector with focus on innovation and a more portfolio approach among the larger companies. 

Ulrica Slåne Bjerke has been part of the investment community for more than 15 years as Portfolio Manager in the Health Care sector, and uses her experience and expertise to manage the Arctic Aurora LifeScience fund.

 

 

 

Arctic Aurora LifeScience is an equity fund investing in global biotechnology and pharmaceutical companies. The fund is run by former portfolio manager in the Swedish Governmental Pension Fund AP3, Ulrica Bjerke, as well as Dr. Torbjørn Bjerke, both with 20 years of experience from the market. Arctic Aurora LifeScience was launched in May 2016 with both hedged and un-hedged share classes.

Past performance in Arctic Aurora LifeScience is no guarantee for future returns. Future returns depend on the market, fund manager skill, fund risk level, costs, among others. Performance in the fund may at times be negative and may for this fund vary considerably within periods.